The FDAs own language makes it clear: Compounded drugs containing BPC-157 may pose risk for immunogenicity and may have complexities with regard to peptide-related impurities and API characterization. In plain terms, the FDA is worried about shady, unregulated research-use-only peptides sold online not about what happens when BPC-157 is responsibly compounded, tested for purity, and dispensed under medical supervision
The field shows increasing innovation in formulation technologies, with nano-curcumin, liposomal preparations, and combination approaches attempting to overcome absorption limitations
GHK-Cu has been shown to improve scar texture, smoothness, and pigmentation by enhancing collagen remodeling
Redox Biol 60:102605
The Importance of FIH Trials in Clinical Development First-in-Human trials provide the first opportunity to translate preclinical evidence into early clinical knowledge
FAQ A: Symptoms indicative of Vitamin B12 deficiency include fatigue, weakness, and neurological problems
